Background <p>Pericardial fat tissue has been proposed as an independent risk factor for cardiovascular disease. Given the limitations of imaging-based quantification in clinical practice, surrogate indices have been proposed as practical tools for estimating ectopic fat accumulation.</p> Objective <p>This study aimed to evaluate the factors associated with increased pericardial fat, estimated using the Dysfunctional Adiposity Index (DAI), a surrogate marker previously proposed for this purpose, in patients with type 2 diabetes without cardiovascular disease.</p> Methods <p>This retrospective cross-sectional study included patients with type 2 diabetes. The DAI was used as a surrogate marker to estimate pericardial fat volume. Binary logistic regression analysis was used to identify independent factors associated with increased pericardial fat.</p> Results <p>A total of 1479 patients with type 2 diabetes were included in the study. Of them, 67.5% had increased pericardial fat volume. The mean age of the subjects was 58.96 ± 14.39&#xa0;years, with a mean body mass index of 28.44 ± 6.11&#xa0;kg/m<sup>2</sup>, a mean HbA1c of 7.74 ± 2.06%, and a median microalbuminuria of 11.06 (2.78–52.82) mg/24&#xa0;h. After multiple logistic regressions, a longer duration of type 2 diabetes, metformin use, higher fasting glucose, microalbuminuria, and LDL-C were positively associated with increased pericardial fat volume. In contrast, male sex and fibrate use were inversely associated.</p> Conclusion <p>A longer duration of type 2 diabetes, metformin use, higher fasting glucose, microalbuminuria, and LDL-C are associated with higher surrogate-estimated pericardial fat. These findings suggest that the DAI may provide insights into ectopic fat accumulation; however, further studies are needed before considering it a reliable non-invasive surrogate marker.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Factors associated with increased pericardial fat estimated by the dysfunctional adiposity index in Mexican patients with type 2 diabetes

  • Froylan D. Martínez-Sánchez,
  • Dulce R. Torres-Arredondo,
  • Valerie P. Vargas-Abonce,
  • Cindy A. Hernández-Cárdenas,
  • Maria J. Corredor-Nassar,
  • Sandra M. Feria-Agudelo,
  • Victor M. Paz-Zarza,
  • Aranza Raichs-Tovany,
  • Erika K. Tenorio-Aguirre

摘要

Background

Pericardial fat tissue has been proposed as an independent risk factor for cardiovascular disease. Given the limitations of imaging-based quantification in clinical practice, surrogate indices have been proposed as practical tools for estimating ectopic fat accumulation.

Objective

This study aimed to evaluate the factors associated with increased pericardial fat, estimated using the Dysfunctional Adiposity Index (DAI), a surrogate marker previously proposed for this purpose, in patients with type 2 diabetes without cardiovascular disease.

Methods

This retrospective cross-sectional study included patients with type 2 diabetes. The DAI was used as a surrogate marker to estimate pericardial fat volume. Binary logistic regression analysis was used to identify independent factors associated with increased pericardial fat.

Results

A total of 1479 patients with type 2 diabetes were included in the study. Of them, 67.5% had increased pericardial fat volume. The mean age of the subjects was 58.96 ± 14.39 years, with a mean body mass index of 28.44 ± 6.11 kg/m2, a mean HbA1c of 7.74 ± 2.06%, and a median microalbuminuria of 11.06 (2.78–52.82) mg/24 h. After multiple logistic regressions, a longer duration of type 2 diabetes, metformin use, higher fasting glucose, microalbuminuria, and LDL-C were positively associated with increased pericardial fat volume. In contrast, male sex and fibrate use were inversely associated.

Conclusion

A longer duration of type 2 diabetes, metformin use, higher fasting glucose, microalbuminuria, and LDL-C are associated with higher surrogate-estimated pericardial fat. These findings suggest that the DAI may provide insights into ectopic fat accumulation; however, further studies are needed before considering it a reliable non-invasive surrogate marker.